Tang Capital Management’s Editas Medicine EDIT Stock Holding History

Tang Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400,000	Closed	-$508K	–	203
2024 Q4	$508K	Buy	+400,000	New	+$1.02M	0.03%	172
2024 Q1	–	Sell	-200,000	Closed	-$2.03M	–	111
2023 Q4	$2.03M	Hold	200,000	–	–	0.19%	89
2023 Q3	$1.56M	Hold	200,000	–	–	0.22%	80
2023 Q2	$1.65M	Buy	+200,000	New	+$1.74M	0.24%	75

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tang Capital Management's EDIT Position: Q1 2025 in Review

Tang Capital Management sold out of Editas Medicine (EDIT) in Q1 2025, closing a stake of 400,000 shares — an estimated $508K sold.

Tang Capital Management first reported a position in EDIT in Q2 2023 and held it in 4 quarters. The position peaked at $2.03M in Q4 2023. 194 funds tracked by Wall St. Rank hold EDIT as of Q1 2025.

Tang Capital Management reported no remaining Editas Medicine position as of Q1 2025 after selling out during the quarter.
Tang Capital Management sold 400,000 Editas Medicine shares in Q1 2025, an estimated $508K.
Tang Capital Management first reported a position in Editas Medicine in Q2 2023 and held it in 4 quarters.
Tang Capital Management's Editas Medicine position peaked at $2.03M in Q4 2023.
194 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2025.

Based on Tang Capital Management's 13F filing for Q1 2025, filed 15 May 2025.